Publication | Open Access

Disruption of SLFN11 Deficiency–Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti–PD-1 Therapy Efficacy in Hepatocellular Carcinoma

Tumor BiologyMedicineLiver PhysiologyImmunologyTumor ImmunityCancer Cell BiologyLiver CancerCancer BiologyCell BiologyCell SignalingHepatocellular CarcinomaCancer Research